NASDAQ:SRTS Sensus Healthcare - SRTS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $5.00 +0.04 (+0.81%) (As of 03/24/2023 02:20 PM ET) Add Compare Share Share Today's Range$4.80▼$5.0450-Day Range$4.96▼$9.4952-Week Range$4.80▼$15.25Volume101,401 shsAverage Volume234,962 shsMarket Capitalization$83.05 millionP/E Ratio3.42Dividend YieldN/APrice Target$16.83 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Sensus Healthcare MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside235.3% Upside$16.83 Price TargetShort InterestHealthy5.21% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.98 out of 5 starsMedical Sector293rd out of 989 stocksSurgical & Medical Instruments Industry28th out of 99 stocks 3.5 Analyst's Opinion Consensus RatingSensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.83, Sensus Healthcare has a forecasted upside of 235.3% from its current price of $5.02.Amount of Analyst CoverageSensus Healthcare has only been the subject of 3 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted5.21% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sensus Healthcare has recently decreased by 6.45%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SRTS. Previous Next 0.0 News and Social Media Coverage Search InterestOnly 21 people have searched for SRTS on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders16.36% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.25% of the stock of Sensus Healthcare is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is 3.44, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.30.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is 3.44, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 100.20.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Sensus Healthcare (NASDAQ:SRTS) StockSensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+, and SRT-100 Vision. Its main product superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers, and other skin conditions, such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.Read More Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address SRTS Stock News HeadlinesMarch 16, 2023 | finance.yahoo.comSensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19March 11, 2023 | benzinga.comSensus Healthcare Stock (NASDAQ:SRTS), Short Interest ReportMarch 24, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.March 11, 2023 | finance.yahoo.comAn Intrinsic Calculation For Sensus Healthcare, Inc. (NASDAQ:SRTS) Suggests It's 39% UndervaluedMarch 6, 2023 | finance.yahoo.comImplied Volatility Surging for Sensus Healthcare (SRTS) Stock OptionsFebruary 12, 2023 | finance.yahoo.comSensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2022 Earnings Call TranscriptFebruary 11, 2023 | finance.yahoo.comDo Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?February 10, 2023 | seekingalpha.comSensus Healthcare drops 21% after Q4 missMarch 24, 2023 | Weiss Ratings (Ad)Bank Accounts: Frozen!In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!February 10, 2023 | finanznachrichten.deSensus Healthcare, Inc.: Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 MillionFebruary 9, 2023 | msn.comSensus Healthcare GAAP EPS of $0.17 misses by $0.06, revenue of $13.1M misses by $0.1MFebruary 9, 2023 | msn.comSensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Lag EstimatesFebruary 9, 2023 | finance.yahoo.comSensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 MillionFebruary 3, 2023 | finance.yahoo.comDoes Sensus Healthcare, Inc. (SRTS) Have the Potential to Rally 81.12% as Wall Street Analysts Expect?February 2, 2023 | finance.yahoo.comEarnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to DeclineFebruary 1, 2023 | finance.yahoo.comSensus Healthcare to Host Fourth Quarter 2022 Financial Results and Business Update Conference Call on February 9, 2023January 23, 2023 | seekingalpha.comSensus Healthcare: Better Outcomes For Painful ProceduresJanuary 18, 2023 | finance.yahoo.comWall Street Analysts Predict a 72.6% Upside in Sensus Healthcare, Inc. (SRTS): Here's What You Should KnowJanuary 18, 2023 | finance.yahoo.comWall Street Analysts Predict a 72.6% Upside in Sensus Healthcare, Inc. (SRTS): Here's What You Should KnowJanuary 17, 2023 | finance.yahoo.comSensus Healthcare, Inc. (NASDAQ:SRTS) most popular amongst individual investors who own 42% of the shares, institutions hold 37%January 9, 2023 | finance.yahoo.comSensus Healthcare Announces Senior Management Appointments and PromotionsJanuary 5, 2023 | finance.yahoo.comSensus Healthcare Announces Preliminary Fourth Quarter 2022 RevenuesDecember 13, 2022 | finance.yahoo.comSensus Healthcare, Inc. (SRTS)November 22, 2022 | finance.yahoo.comHere Are 2 Stocks I'm Focused on Right NowNovember 11, 2022 | finance.yahoo.comEven though Sensus Healthcare (NASDAQ:SRTS) has lost US$94m market cap in last 7 days, shareholders are still up 106% over 3 yearsNovember 7, 2022 | benzinga.comShort Volatility Alert: Sensus Healthcare, Inc.November 7, 2022 | finance.yahoo.comDown 46.9% in 4 Weeks, Here's Why Sensus Healthcare, Inc. (SRTS) Looks Ripe for a TurnaroundSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address SRTS Company Calendar Last Earnings2/09/2023Today3/24/2023Next Earnings (Estimated)5/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees37Year FoundedN/APrice Target and Rating Average Stock Price Forecast$16.83 High Stock Price Forecast$20.00 Low Stock Price Forecast$14.50 Forecasted Upside/Downside+236.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$1.46 Trailing P/E Ratio3.43 Forward P/E Ratio6.34 P/E GrowthN/ANet Income$24.24 million Net Margins54.44% Pretax Margin65.01% Return on Equity25.55% Return on Assets20.84% Debt Debt-to-Equity RatioN/A Current Ratio7.83 Quick Ratio7.47 Sales & Book Value Annual Sales$44.53 million Price / Sales1.87 Cash Flow$0.27 per share Price / Cash Flow18.58 Book Value$1.57 per share Price / Book3.19Miscellaneous Outstanding Shares16,610,000Free Float13,894,000Market Cap$83.22 million OptionableNot Optionable Beta0.67 Key ExecutivesJoseph C. SardanoChairman & Chief Executive OfficerMichael J. SardanoPresident, Secretary & General CounselMagdalena MartinezChief Operating OfficerJavier RampollaChief Financial OfficerRuss PriceDirector-EngineeringKey CompetitorsNeovascNASDAQ:NVCNNeuroneticsNASDAQ:STIMApyx MedicalNASDAQ:APYXNeuroPaceNASDAQ:NPCELyra TherapeuticsNASDAQ:LYRAView All CompetitorsInsiders & InstitutionsRockefeller Capital Management L.P.Bought 3,000 shares on 3/6/2023Ownership: 0.042%DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am MainBought 72,093 shares on 2/16/2023Ownership: 0.434%State of WyomingBought 8,323 shares on 2/16/2023Ownership: 0.050%G2 Investment Partners Management LLCSold 314,375 shares on 2/15/2023Ownership: 0.890%Millennium Management LLCBought 15,635 shares on 2/15/2023Ownership: 0.253%View All Insider TransactionsView All Institutional Transactions SRTS Stock - Frequently Asked Questions Should I buy or sell Sensus Healthcare stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SRTS shares. View SRTS analyst ratings or view top-rated stocks. What is Sensus Healthcare's stock price forecast for 2023? 3 Wall Street analysts have issued twelve-month price objectives for Sensus Healthcare's shares. Their SRTS share price forecasts range from $14.50 to $20.00. On average, they expect the company's stock price to reach $16.83 in the next year. This suggests a possible upside of 236.0% from the stock's current price. View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts. How have SRTS shares performed in 2023? Sensus Healthcare's stock was trading at $7.42 at the beginning of 2023. Since then, SRTS stock has decreased by 32.5% and is now trading at $5.01. View the best growth stocks for 2023 here. When is Sensus Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our SRTS earnings forecast. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) issued its quarterly earnings data on Thursday, February, 9th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.26 by $0.09. The firm had revenue of $13.11 million for the quarter, compared to analyst estimates of $13.25 million. Sensus Healthcare had a net margin of 54.44% and a trailing twelve-month return on equity of 25.55%. What ETF holds Sensus Healthcare's stock ? First Trust Dow Jones Select Microcap Index Fund holds 31,433 shares of SRTS stock, representing 0.13% of its portfolio. What guidance has Sensus Healthcare issued on next quarter's earnings? Sensus Healthcare issued an update on its fourth quarter 2022 earnings guidance on Thursday, January, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $13.00M-, compared to the consensus revenue estimate of $12.25 million. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM). When did Sensus Healthcare IPO? (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.08%), Empirical Financial Services LLC d.b.a. Empirical Wealth Management (0.90%), G2 Investment Partners Management LLC (0.89%), Navellier & Associates Inc. (0.75%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (0.43%) and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (0.43%). Insiders that own company stock include Javier Rampolla, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall. View institutional ownership trends. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $5.01. How much money does Sensus Healthcare make? Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $83.22 million and generates $44.53 million in revenue each year. The company earns $24.24 million in net income (profit) each year or $1.46 on an earnings per share basis. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071. This page (NASDAQ:SRTS) was last updated on 3/24/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.